AR2012_WebVersion

CONTENTS

SECTION 1

Year in Review

page 03

SECTION 2

ABOUT US

page 06

SECTION 3

Corporate Governance

page 18

SECTION 4

ANIMAL HEALTH Programmes

page 21

SECTION 5

Financial Report

page 25

An i ma l H e a lt h I r e l and

1

SECTION 1: YEAR IN REVIEW

Chairman’s address

The past year has been another active one for AHI. The range of activities in which we are involved and the challenges we face both continue to grow as the organisation has moved into the delivery phase of two major national programmes, BVD and CellCheck. The level of commitment on the part of AHI staff and our various stakeholders has had to rise to meet these challenges; for example, within the BVD programme in 2012, twenty-three public meetings were held, in addition to fourteen meetings of the Implementation Group and two meetings of the Technical Working Group. The activity in the CellCheck programme was no less intense. The cross-border collaboration with Northern Ireland in relation to the BVD programme and the emerging Johne’s disease programme has been very encouraging, I would like to express my gratitude to John Thompson, Chairman of Animal Health and Welfare NI, and to his Board for the collaborative and collegial approach they have taken to our joint work. As ever, the financial and other support of the stakeholders, the wise counsel of my fellow Directors, and the commitment of the CEO and the staff of AHI have been fundamental in enabling the organisation to deliver on behalf of the industry, and I wish to extend my most sincere thanks to all of these individuals and organisations.

Mike Magan Chairman, AHI

An i ma l H e a lt h I r e l and

4

Chief Executive Officer’s report

It would not be possible to reflect on 2012 without marking out for particular mention the development of the first corporate strategy for Animal Health Ireland. Covering the period 2012-2014, the strategy was developed in close consultation with all relevant parties, including the stakeholders and Members of AHI, the Board and the Technical Working Groups. In any organisation, but most particularly in a small organisation such as AHI, it is vital to be absolutely clear as to what objectives can be achieved with llimited resources, and the value of this strategy is that it identifies a clear set of strategic priorities for AHI in the period up to the end of 2014 that are challenging, but nonetheless achievable from within the existing resource base. In this period, AHI will concentrate its resources on four programmes:

• Bovine Viral Diarrhoea (BVD) • CellCheck (mastitis/SCC control) • Johne’s disease • Infectious Bovine Rhinotracheitis (IBR)

Business plans with specific milestones and timelines in respect of each of the above programmes were developed in 2012 and these and their subsequent iterations will be used as the basis on which to report progress back to AHI’s stakeholders and Members on an annual basis. In addition to these priority programmes, several other important work-streams have been identified, relating to Biosecurity, CalfCare (calf health), parasite control and animal health economics, and AHI has committed to delivering a series of specific actions in respect of each of these within the lifetime of the current strategy. The last quarter of 2012 saw intense activity aimed at finalising preparations for the start of the compulsory phase of the national BVD eradication programme on January 1st 2013. The operation of the voluntary phase of the programme in 2012 proceeded smoothly, testament to the very positive engagement with the programme by Irish farmers, and the huge efforts of the Programme Manager, Dr. David Graham, supported by the BVD Implementation and Technical Working Groups. Dr. Graham was also very active in Northern Ireland, where he assisted Animal Health and Welfare Northern Ireland (AHWNI) to gear up for the start of a voluntary phase of a BVD eradication programme in January 2013. The level of cooperation between the two jurisdictions at the start of a major animal health programme in the bovine sector is, to my knowledge, unprecedented, and bodes well for future co-operation right across the island in relation to the control of infectious animal diseases. In September 2012, AHI and AHWNI signed a Memorandum of Understanding to enable the effective sharing of resources between the two organisations, and the cost-effective delivery of major disease control programmes on an all-island basis. AHI’s other major national programme, CellCheck, has also been very active in 2012, and Finola McCoy, the Programme Manager, summarises the major developments below. These include the launch by Minister Simon Coveney of the ‘CellCheck Farm Guidelines for Mastitis Control’ and the commencement of the training of service providers. The completion of service-provider training will create the basis for the all-important engagement with dairy farmers through farmer workshops, the roll-out of which will commence in 2013 and accelerate in 2014 in advance of the end of the milk quota regime. I look forward to the opportunity at our forthcoming Annual General Meeting to reporting the very good delivery that has been achieved against the targets set out in the 2012 Business Plans, testament to the commitment of the Chairs and members of the various Technical and Implementation Groups, and most especially to the positive engagement by the dairy and livestock farmers of Ireland with our various programmes.

Joe O’Flaherty Chief Executive, AHI

Annua l R e p o r t 2012 5

SECTION 2: About us

The Company Animal Health Ireland (AHI) is an industry-led, not-for-profit partnership between livestock producers, processors, animal health advisers and government. Its remit includes diseases and conditions of livestock which are endemic in Ireland, but which were not, when AHI was established, subject to regulation and coordinated programmes of control. AHI is a Company Limited by Guarantee and not having a Share Capital, incorporated as such under the Companies Acts (1963-2006) on 11th May 2009. The Memorandum and Articles of Association of the Company are available to view on the AHI website 1 . Animal Health Ireland is 50% funded by the Department of Agriculture, Food & The Marine (DAFM) and 50% by private sector investors. On the establishment of the Company in 2009, DAFM committed to provide AHI a maximum amount of €500,000 per annum for a period of 5 years, subject to the receipt of a matching contribution by non-State sources, and to the provisions made in the Annual Estimates of Public Expenditure. In establishing the appropriate level of contribution by individual private sector Stakeholders, account is taken of the size of the organisation and of the nature of the business in which it is engaged. The Members The Members are the various organisations that set the overall strategic direction of the organisation and that provide the necessary financial and other resources to enable Animal Health Ireland to operate effectively. Members have entitlement to vote at General Meetings, and where voting by poll takes place, each Member is entitled to one ‘Contribution Vote’ in respect of every €3,000 of Annual Financial Contribution to the Company. As of 31st December 2012, the following organisations were Stakeholders and/or Members in Animal Health Ireland (* indicates membership). The Register of Members is available to view from the Member Area of the AHI website. Dairy and Beef Processors ABP Ireland* Arrabawn Co-op*

Carbery Group* Connacht Gold* Dairygold Co-op* Dawn Meats* Glanbia* Kepak Group* Kerry Agribusiness* Lakeland Dairies* Slaney Foods* Tipperary Co-op*

Town of Monaghan Co-op Wexford Milk Producers*

1 http://www.animalhealthireland.ie/page.php?id=68

Annua l R e p o r t 2012 7

Farmers’ organisations Irish Cattle and Sheep Farmers’ Association (ICSA)* Irish Charolais Cattle Society* Irish Co-operative Organisation Society (ICOS)* Irish Creamery Milk Suppliers’ Association (ICMSA)* Irish Farmers’ Association (IFA)* Irish Holstein Friesian Association (IHFA)* Irish Milk Quality Co-operative Society (IMQCS) Macra na Feirme* Pedigree Cattle Breeders’ Council of Ireland* Professional/Advisory/Support services Cork Marts* DAFM – Veterinary Lab Services* ICBF* Irish Dairy Board UCD Veterinary Ireland* Government and State Agencies Bord Bia* Department of Agriculture, Food and the Marine* Teagasc*

An i ma l H e a lt h I r e l and

8

The Board The Board of Animal Health Ireland comprises seven non-executive Directors. During the year, the Directors of Animal Health Ireland were:

Director

Date of appointment (reappointment)

May 2009 (December 2012) May 2009 May 2009 May 2009 May 2009 May 2009 (December 2012)

Mr. Mike Magan, Chairman (Dairy Farmer) Mr. Gerard Brickley (Bord Bia)* Mr. Joe Collins (Irish Dairy Board) Professor Michael Doherty (UCD) Mr. John O’Sullivan (Dairy Farmer) Mr. Robin Talbot (Beef Farmer)

Rotation of Chairman and Directors The Articles of Association of AHI provide that the first Chairman appointed shall hold office until the termination of the first Board meeting following the Third Annual General Meeting and shall then retire but shall be eligible for re-election. Thereafter, subject to the provisions of the Articles, the Chairman from time to time shall hold office from the termination of the Board meeting at which he was elected until termination of the first Board meeting following the third next Annual General Meeting following his election. In relation to Directors, the Articles of Association state that at the first Board meeting following every third Annual General Meeting a number of Directors shall retire from office according to the following sequence: two Directors shall retire at the first such Board meeting, three Directors shall retire at the second such Board meeting, two Directors shall retire at the third such Board meeting and thereafter the Directors shall rotate according to the same sequence repeated from time to time 2 . At the Board meeting of 11th December 2012, following written consultation with the Members, Mike Magan retired as Chairman and Director of AHI and Robin Talbot retired as Director. Bothwere reappointed as Directors, and Mike Magan was subsequently unanimously re-elected by the Board as Chairman of AHI. Directors’ remuneration Directors of AHI who are public servants are precluded from drawing an Honorarium from the Company under the ‘one person one salary’ principle 3 . One of the Directors serving in 2012 was precluded from receiving fees from Animal Health Ireland on this basis. The payment of fees to those Directors eligible to receive them is subject to compliance with the Code of Practice for the Governance of State Bodies 4 , and fees are subject to taxation.

* Gerard Brickley retired from Bord Bia in February 2012. 2 Articles 35 and 45 of the Articles of Association set out the rules governing the appointment and retirement of Chairmen and Directors. 3 Established by the Review Body on Higher Remuneration in the Public Service (1972). 4 As approved in October 2001 (Appendix D).

Annua l R e p o r t 2012 9

The Management Team At 31st December 2012 , the permanent staff of Animal Health Ireland comprised the following:

Name

Title

Date of employment

Mr. Joe O’Flaherty Ms. Nuala Morgan Dr. David Graham Mr. Karol Harvey Ms. Fionnuala Malone Ms. Jackie Dempsey Ms. Grainne Dwyer

Chief Executive Officer Company Secretary Programme Manager (Biosecure Diseases) Planning & Operations Manager Technical Working Group Liaison Administrative Assistant (Part-time) Communications Manager

24/09/2009 08/03/2010 01/10/2010 29/11/2010 16/03/2011 01/03/2012 01/09/2012

Finola McCoy (CellCheck Programme Manager) In addition to the staff directly employed by the Company at 31st December 2012, under the terms of a Collaboration Agreement between Teagasc and AHI, a member of Teagasc staff, Ms. Finola McCoy, was assigned on a full-time basis to the position of ProgrammeManager for the national mastitis control programme, CellCheck. Technical Working Groups The Technical Working Groups (TWGs) comprise experts and experienced practitioners from a variety of fields who are tasked with drawing up factual resources, the development of decision-making tools, and the identification of areas for further Research and Development. Furthermore, in areas in which AHI is developing disease control and eradication programmes of national scope, the TWGs, in conjunction with the relevant Implementation Group (IG), are responsible for the development and implementation of these programmes. By giving of their time free of charge, these experts enable AHI access the technical resources required to develop its various programmes at a fraction of the true commercial cost of such expertise. Animal Health Ireland gratefully acknowledges the generosity of these individuals and that of their parent organisations and employers in this regard. As of 31st December 2012, seven Technical Working Groups were operational and had met on at least one occasion over the course of 2012. Further details of the Technical Working Groups, including biographies of the Chairmen and members, are available at http://www.animalhealthireland.ie/page.php?id=205

An i ma l H e a lt h I r e l and

10

Member Name Biosecurity TWG

2 meetings held between 1/1/2012 and 31/12/2012

Parent Organisation

Meetings attended

Teagasc Manager, Tully Bull Performance Centre, Kildare MSD National Cattle Breeding Centre Retired UCD AHI Veterinary Practitioner Technical Working Group Rapporteur AHI Central Vet Research Laboratory UCD DAFM, Veterinary Laboratory Services Veterinary Practitioner UCD DAFM, Veterinary Laboratory Services MSD National Cattle Breeding Centre AHI DAFM, Veterinary Laboratory Services Technical Working Group Rapporteur AHI Teagasc Veterinary Practitioner UCD Independent Milk Laboratories 2 meetings held between 1/1/2012 and 31/12/2012 Parent Organisation

John Mee (Chair) Stephen Conroy Bosco Cowley Bernard Eivers Richard Fallon Tim Geraghty David Graham Pat Kirwan Fionnuala Malone John Moriarty Luke O’Grady Ronan O’Neill Michael Sexton

2 0 2 0 2 2 (by phone)

0 2 2 2 1 2 0 2 1 2 2 2 2 2 0 2 1 1

BVD TWG

Member Name

Meetings attended

Michael Doherty (Chair) Damien Barrett

Bosco Cowley Bernard Eivers David Graham Ronan O’Neill Fionnuala Malone John Mee Michael Sexton

Luke O’Grady Riona Sayers

Annua l R e p o r t 2012 11

IBR TWG

6 meetings held between 1/1/2012 and 31/12/2012

Member Name

Parent Organisation

Meetings attended

Retired Pfizer Animal Health Manager, Tully Bull Performance Centre, Kildare Munster AI MSD Communications Consultant National Cattle Breeding Centre UCD AHI AFBI NI Veterinary Practitioner Technical Working Group Rapporteur AHI Veterinary Practitioner DAFM Pfizer Animal Health DAFM, Veterinary Laboratory Services Independent Milk Laboratories UCD DAFM, Veterinary Laboratory Services MSD Teagasc UCD DAFM Merial PVP Teagasc Veterinary Practitioner Veterinary Laboratory Services Norbrook Technical Working Group Rapporteur AHI UCD CVRL DAFM DAFM 2 meetings held between 1/1/2012 and 31/12/2012 Parent Organisation

Michael Gunn (Chair) Charles Chavasse Stephen Conroy Doreen Corridan

6 2 1 3 4 1 2 5 (4 by phone)

Bosco Cowley Grainne Dwyer Bernard Eivers

Tim Geraghty David Graham Maria Guelbenzu Donal Lynch Fionnuala Malone Shane McElroy John Melville

5 3 2 5 3 2 2 6 5 2 1 2 0 1 1 1 1 0 1 2 1 2 0 1 1

Mary Newman Ronan O’Neill Riona Sayers

Parasite Control TWG

Member Name

Meetings attended

Michael Doherty (Chair) Micheal Casey Bosco Cowley Martin Danaher

Theo De Waal June Fanning Andrew Forbes John Gilmore Barbara Good Fintan Graham Ian Hogan Maura Langan Fionnuala Malone Grace Mulcahy

Tom Murphy Donal Toolan

An i ma l H e a lt h I r e l and

12

Member Name CalfCare TWG

3 meetings held between 1/1/2012 and 31/12/2012

Meetings attended

Parent Organisation

UCD Teagasc Pfizer Animal Health Teagasc DAFM, Veterinary Laboratory Services Retired Volac Ireland Veterinary Practitioner DAFM, Veterinary Laboratory Services Teagasc Technical Working Group Rapporteur AHI Teagasc UCD DAFM, Veterinary Laboratory Services Cork County Council Veterinary Practitioner Retired DAFM AHI CVRL, DAFM Technical Working Group Rapporteur AHI Teagasc Veterinary Practitioner DAFM AFBI NI UCD Parent Organisation

Ingrid Lorenz (Chair) Muireann Conneely Charles Chavasse Bernadette Earley John Fagan Richard Fallon Liam Gannon John Gilmore Ian Hogan Emer Kennedy Fionnuala Malone John Mee Simon More (Chair) Damien Barrett Jim Buckley Bill Cashman Richard Fallon Margaret Good David Graham Kevin Kenny Fionnuala Malone John Mee Ciaran Mellett Peter Mullowney Samuel Strain Paul Whyte

3 3 2 2 3 3 3 1 2 1 3 1 4 2 0 4 4 4 2 3 3 1 3 3 3 3

Johne’s disease TWG

4 meetings held between 1/1/2012 and 31/12/2012

Member Name

Meetings attended

Annua l R e p o r t 2012 13

Member Name CellCheck TWG

2 meetings held between 1/1/2012 and 31/12/2012 Parent Organisation

Meetings attended

UCD Riverview Veterinary Clinic

Simon More (Chair) Willie Buckley Don Crowley Brendan Dillon Kevin Downing Edmond Harty Alan Johnson Patrick Kelly Fionnuala Malone Finola McCoy Luke O’Grady Frank O’Sullivan George Ramsbottom Tom Ryan

2 0 1 1 1 0 0 0 2 2 2 2 0 2

Teagasc Glanbia ICBF HerdPlus Dairymaster DAFM Veterinary Laboratory Services Munster AI Technical Working Group Rapporteur AHI AHI / Teagasc UCD Veterinary Practitioner

Teagasc Teagasc

An i ma l H e a lt h I r e l and

14

Implementation and Consultation Groups In conjunction with the relevant Technical Working Group, the Implementation Groups (IGs) are responsible for the development, implementation and monitoring of major animal health programmes. Members of the Implementation Groups are drawn from the relevant AHI stakeholder organisations. Over the course of 2012, Implementation Groups for the BVD eradication programme and for the Johne’s disease control programme, and an Industry Consultation Group for CellCheck, were operative. Further details of the Implementation Groups are available at http://www.animalhealthireland.ie/page.php?id=206. BVD Implementation Group

BVD IG

14 meetings held between 1/1/2012 and 31/12/2012 Parent Organisation

Member Name

Meetings attended

AHI Programme Manager, AHI (UCD, Chair of BVD TWG) UCD/TWG TWG

Joe O’Flaherty (Chair) David Graham Prof Michael Doherty

14 13 6 1 1 7 13

Luke O’Grady Bosco Cowley Grainne Dwyer Karol Harvey Mike Magan Martin Blake Pat Brangan Micheal Casey Donal Sammin Sean Coughlan Mike Lynch Mary Buckley John Enright Michael Guinan Pat McCormack Ray Doyle Michael Biggins Tomás Bourke Tom Phelan John Waters Richard Whelan John Donworth Conor Geraghty Pat Kirwan Donal Lynch Finbarr Murphy John O’Roarke Colin Smyth Donal Carey Louis Byrne

AHI AHI AHI

1 3 2 5 7 8 7 1 1 3 7 5

DAFM DAFM DAFM DAFM

ICBF ICBF

ICMSA ICMSA ICMSA ICMSA ICOS

IFA IFA IFA IFA

11 13 11 13 9 5 7 11 9 6 9 3 11 1

IHFA IHFA PCBCI Teagasc

Veterinary Ireland Veterinary Ireland Veterinary Ireland Veterinary Ireland Veterinary Ireland UFU (Observer)

Annua l R e p o r t 2012 15

CellCheck Industry Consultation Group

Cellcheck ICG

3 meetings held between 1/1/2012 and 31/12/2012 Parent Organisation

Member Name

Meetings attended

AHI Programme Manager

Mike Magan (Chair) Finola McCoy Joe O’Flaherty Karol Harvey

3 3 1 3 1 2 2 2 2 2 1 1 1 1 2 1 1 2 2 2 2 1 5 5 5 5 1 4 2 3 3 4 4 1 2

AHI AHI AHI ACA

Grainne Dwyer Martin Crowe

Arrabawn Co-op Arrabawn Co-op Carbery Connacht Gold Connacht Gold DAFM Dairygold Glanbia Glanbia ICMSA IFA IMQCS Kerry Agribusiness Lakeland Dairies Lakeland Dairies Teagasc

Jerry Ryan Tom Starr

Sinead Treanor Paul Cullinane Anthony Walsh Martin Blake Liam O’Flaherty

Anne Browne Brendan Dillon Pat McCormack Catherine Lascurettes George Kearns Joe Moriarty Dermot Coyle Tom Downes George Ramsbottom

Johne’s disease Implementation Group

JD IG

5 meetings held between 1/1/2012 and 31/12/2012 Parent Organisation

Member Name

Meetings attended

AHI Programme Manager, AHI (UCD, Chair of JD TWG) AHI AHI/AHWNI AHI

Joe O’Flaherty (Chair) David Graham Prof Simon More Mike Magan Sam Strain Karol Harvey

ABP Ireland ABP Ireland

Maria Kilmartin Paul Matthews Derry Connolly John O’Brien Sinead Treanor Micheal Casey Michael Sheridan

Carbery Carbery Carbery

DAFM DAFM

An i ma l H e a lt h I r e l and

16

Johne’s disease Implementation Group (continued)

JD IG

5 meetings held between 1/1/2012 and 31/12/2012 Parent Organisation

Member Name

Meetings attended

DAFM-VLS DAFM-VLS Dairygold Dairygold Glanbia

John Egan Donal Sammin Dan Curtin Eamon O’Sullivan Shane McElroy Sean Coughlan Mike Lynch Michael Guinan Ciaran Dolan Pat McCormack Geoff Hamilton Micheal Ahern Marese Walsh Tomás Bourke Teddy Cashman Paddy Donnelly John Enright Gerald Quain Charlie Gallagher Richard Whelan Kieran Collins Sinead Breen Pat Shiels Doreen Corridan Pat Mulvehill Louis Byrne Laurence Feeney Donal O’Donnell Andy Shannon John Donworth Tom O’Dwyer Ciaran Mellett Bill Cashman Conor Geraghty Donal Lynch John O’Roarke Kevin Kiersey Sean O’Leary John Waters Donal Carey

2 4 4 2 4 2 4 5 3 2 1 3 1 3 1 5 1 3 1 2 4 1 4 1 2 1 1 1 1 4 4 3 1 1 1 2 4 1 1 1

ICBF ICBF

ICMSA ICMSA ICMSA ICMSA ICMSA ICSA

IDB IDB IFA IFA IFA IFA IFA IFA

IHFA IHFA IHFA Kerry Agribusiness Lakeland Dairies Lakeland Dairies

Munster AI Munster AI PCBCI

Progressive Genetics Progressive Genetics Progressive Genetics

Teagasc Teagasc TWG

Veterinary Ireland Veterinary Ireland Veterinary Ireland Veterinary Ireland

Annua l R e p o r t 2012 17

SECTION 3: CORPORATE GOVERNANCE

An i ma l H e a lt h I r e l and

18

General meetings of Members The Third Annual General Meeting of the Company was held in Dublin on 14th June 2012. Following an opening address by Simon Coveney, T.D., Minister for Agriculture, Food and the Marine, the financial statements for the year ended 31st December, 2011 and the report of the Directors and Auditors thereon were adopted. A detailed report on AHI strategy (2012-2014) and delivery against Business Plans of the four priority programmes was provided by the CEO. The Minutes of this and previous AGMs are available to members through the stakeholder portal on the AHI website. Board meetings The Board met on three occasions between 01/01/2012 and 31/12/2012. The attendance of Directors at these meetings is summarised below:

Director

Meetings attended

M. Magan (Chairman) G. Brickley J. Collins

3 3 2 2 3 3

M. Doherty J. O’Sullivan R. Talbot

Committees As of 31st December 2012, the only committee constituted by the Directors was the Remuneration Committee, which was first convened on 5th February 2010. 1 meeting of the Remuneration Committee took place in 2012.

Member

Meetings attended

1 1 1 1

J. O’Sullivan (Chairman) J. Collins R. Talbot J. O’Flaherty

Annua l R e p o r t 2012 19

Memoranda of Understanding Memoranda of Understanding have been developed between AHI and the organisations listed below. These memoranda are available for inspection by Members upon request.

Organisation

Date of entry into force

14/06/2010 01/09/2010 22/09/2010 03/06/2011 18/06/2012 26/09/2012

Department of Agriculture, Food and the Marine Teagasc Agri-Food & Biosciences Institute Glanbia UCD AHWNI

Performance monitoring Detailed business plans are produced annually by the management team, following consultation with the Board, the Members, the Technical Working Groups and the Implementation Groups. Account for progress against these business plans is provided to Members annually at the AGM and quarterly through the AHI newsletter. Quarterly management accounts of the Company are also available to Members through the Stakeholder portal of the AHI website.

An i ma l H e a lt h I r e l and

20

SECTION 4: ANIMAL HEALTH PROGRAMMES

Space restrictions preclude the provision here of comprehensive reviews of all of the work programmes and the following summary is therefore confined to those programmes of national scope which had proceeded to an implementation phase as of 31st December 2012. Regular updates on these and all other programmes are provided in the quarterly newsletters, which are available from the AHI website.

BVD

Dr. David Graham, Programme Manager for the biosecure diseases

The industry-led national BVD eradication programme moved from planning to implementation on 1st January 2012, with the commencement of the voluntary phase of the programme, supported by promotional and educational activities. A detailed review of the first six months of the voluntary phase of the programme was completed in September 2012. Key findings included the following: Programme uptake. During the review period, results for 392,858 calves born in 2012 from 8,770 herds were reported to the database (with total tag orders of ~600,000). Results of initial testing. Overall 0.61%, 0.02%, 0.44% and 98.93% of calves tested gave positive, inconclusive, empty (no tissue present) and negative results, respectively. In total 15.2% of herds had one or more calves with an initial positive or inconclusive result. The likelihood of testing positive increased with herd size for all herd types. Confirmatory testing of calves. 1,013 calves with an initial positive or inconclusive result were retested. Overall 79.1% gave a further positive result, consistent with their being persistently infected (PI) with BVD virus. Follow up testing of dams. ~10% of dams of calves that were confirmed as PI also tested positive for BVD virus, strongly suggesting that they in turn were PI. Disposal of calves with an initial positive or inconclusive result. At the end of the review period around two thirds of calves with an initial positive or inconclusive result were dead. As expected, the retention rate of calves was higher in beef herds than in dairy herds. Designated laboratories. Labs performed well, dealing with a throughput which at the peak of spring calving exceeded 35,000 samples per week, while maintaining an average turnaround time of less than 5 days. Farmer survey. The majority of the farmers participating in the programme were satisfied or very satisfied with the programme and found the guidelines easy to comply with. In early September the BVD Implementation Group (IG) took the decision to formally endorse progressing to a compulsory phase in 2013. This was facilitated by the award by DAFM of a tender for the provision of tissue- sample enabled official identity tags, allowing the programme to operate without the routine requirement for a third tag in each calf, and the drafting of legislation (the Bovine Viral Diarrhoea Virus Order (2012)) to provide the necessary legislative basis for the compulsory phase to begin. Key requirements in the legislation included: an obligation to carry out tissue tag testing on all calves born on or after 1st January 2013; a prohibition on

An i ma l H e a lt h I r e l and

22

the movement of animals born after that date without a current negative BVD test result; additional testing where an animal is suspected of being infected with BVD virus (typically the mother of a virus positive calf); the option to carry out a confirmatory test following an initial positive result; and display of BVD test details on mart display boards. The formal announcement of the compulsory phase of the programme was made by Simon Coveney T.D., Minister for Agriculture, Food & the Marine, at the National Ploughing Championships in September. A detailed communications strategy was drawn up by the BVD IG to promote the compulsory phase of the programme, with the focus on twenty three farmer meetings across the country, supplemented by articles in the farming press and interviews on local radio. Presentations were also made to veterinary practitioners and Teagasc advisors. Programme documentation, including information leaflets for farmers and vets, was revised and the BVD section of the AHI website (www.bvdfree.ie) updated in preparation for the commencement of the compulsory phase. New web-based tools for supporting and monitoring the programme were developed by ICBF. To cope with the anticipated volumes of telephone queries a helpdesk run by DAFM and AHI staff was put in place. During the year, linkages were developed with research institutes elsewhere in Europe with an interest in BVD, including the Agri-Food and Biosciences Institute in Belfast, Scotland’s Rural College (SRUC), the Friedrich- Loeffler-Institut (FLI) in Germany and the University of Veterinary Medicine and Pharmacy in Slovakia. During 2012, Dr. David Graham also provided programme management to support the development of a BVD eradication programme in Northern Ireland under the auspices of Animal Health and Welfare NI, working toward the introduction of a voluntary tag-based programme on 1st January 2013.

CellCheck Finola Mc Coy, Teagasc, CellCheck Programme Manager

CellCheck Farm Guidelines for Mastitis Control These are practical, evidence-based best practice recommendations to assist mastitis control, supported by the latest science and research. This resource, which was developed by the CellCheck Technical Working Group, was officially launched in February 2012, by Simon Coveney T.D., Minister for Agriculture, Food & the Marine. The CellCheck Farm Guidelines for Mastitis Control have been very positively received by farmers and service providers alike, as a user-friendly manual, providing clear, consistent and independent information. Stage 1 Service Provider training: The first phase of engagement with service providers commenced in February, with seven Stage 1 service- provider seminars being held in locations around the country, followed by another four seminars in June. Over 500 people attended the 11 events, with almost equal numbers of vets, milking machine technicians, farm advisors and co-op advisors participating. The seminars focused on a number of key messages, such as the economic return from lower cell counts, recognition of the roles that the various service-providers can play in controlling cell counts, and the value of working together in multi-disciplinary teams. Attendees were provided with an outline of the proposed phases of CellCheck service-provider training and an introduction to the CellCheck Farm Guidelines for Mastitis

Annua l R e p o r t 2012 23

Control, followed by a series of practical workstations where the technical aspects of some key best-practice recommendations were discussed. Feedback was very positive and most participants expressed an interest in partaking in further training and CellCheck activities. Stage 2 Service Provider training: The second phase of service provider training commenced in November 2012. The purpose of Stage 2 training was to provider local service providers with the skills, tools and networks required to deliver CellCheck Farmer Workshops, as part of a 4-person, multidisciplinary delivery team. 12 training dates in locations around the country were confirmed, to continue into early 2013. CellCheck Farmer Workshops: The delivery of introductory CellCheck Farmer Workshops commenced in September 2012, with numbers of workshops delivered increasing as the database of Stage 2-trained service providers grew. The objective of these workshops is to help farmers understand the causes of mastitis and to highlight how making simple changes in their everyday milking routines can improve and maintain lower SCC levels in their herd. The workshops are farm-based, and are a combination of classroom-style teaching, group discussion and practical workstations. Group sizes are small, with an average of 14 farmers per workshop, and the emphasis is on active learning. Participation costs €30 per farmer, and this fee goes to AHI to partially offset the cost of workshop development and delivery. By the end of 2012, approximately eight pilot workshops had been held. Regional co-ordinators: 7 regional coordinators were identified in 2012. The role of these individuals, who are all employees of stakeholder milk processors, is to act as a local point of contact and information on the CellCheck programme, and to coordinate CellCheck Farmer Workshops, together with local service providers. They also provide the CellCheck team with feedback from the field to ensure continued improvement of the programme. Economic research: Economic research by Una Geary in Teagasc continued, with the publication in the Journal of Dairy Science of a scientific paper ‘Estimating the effect of mastitis on the profitability of Irish dairy farms’. This work enabled the development of the CostCheck calculator, which was launched in November 2012. This interactive cost calculator, which is available online from the AHI and Teagasc websites, allows farmers to see the financial benefits of lower SCC by quantifying the financial gain that can be achieved by reducing SCC from current levels to a given target level. Economic research by Teagasc into the cost of mastitis has continued, with the focus now shifting to the costs to the processing industry. Social Science Steering Group: The social science steering group continued to meet throughout 2012, supporting the further development of the CellCheck programme, with a particular emphasis on programme evaluation. Work by this group, examining the drivers and constraints to improving milk quality at industry level, and the challenges inherent in working collectively towards a common goal, has been peer-reviewed and published in the Journal of Dairy Science under the title ‘Opportunities and constraints to improving milk quality in Ireland: enabling change through collective action’. Communications: The programme manager, Finola Mc Coy, made presentations on the CellCheck programme at several national and international agricultural and mastitis conferences, including the National Mastitis Council Annual Conference (USA), the British Mastitis Conference, the Dairy Australia/Countdown Downunder Mastitis symposium, and the National Dairy Conference (Teagasc). Monthly articles continued to be produced, appearing on the first week of every month in the Irish Farmer’s Journal, Teagasc Management Notes and in many stakeholder supplier/client newsletters.

An i ma l H e a lt h I r e l and

24

SECTION 5: FINANCIAL REPORT

Animal Health Ireland Initiative Period Ended 31 st December 2012

Contents

Page

Directors and Other Information

27

Directors’ Report

28

Independent Auditors’ Report

30

Income and Expenditure Account

32

Balance Sheet

33

Cashflow Statement

34

Accounting Policies

35

Notes to the Financial Statements

36

An i ma l H e a lt h I r e l and

26

Directors and Other Information Board of Directors M. J. Magan (Chairman)

J. G. Brickley J. O’Sullivan L. J. Collins M. L. Doherty R. Herbert Talbot Dr. Seán Brady (appointed 19th March 2013)

Secretary and Registered Office N. Morgan Main Street, Carrick-on-Shannon, Co. Leitrim. Registered Number: 470675

Statutory Auditors Spain, Fewer, Quinlan & Co., Chartered Accountants & Registered Auditors,

The Mall, Thurles, Co. Tipperary.

Solicitors Frank Mulvey Solicitors, Castle Building, Friary Road, Naas, Co. Kildare.

Accountants & Business Advisors Russell Brennan Keane, RBK House, Irishtown, Athlone, Co. Westmeath.

Bankers Bank of Ireland, Carrick-on-Shannon, Co. Leitrim

Annua l R e p o r t 2012 27

Directors’ Report

The directors present herewith the audited financial statements for the year ended 31st December 2012. Statement of Directors’ Responsibilities The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and generally accepted accounting practices in Ireland including the accounting standards issued by the Accounting Standards Board and published by the Institute of Chartered Accountants in Ireland. Irish company law requires the directors to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the company and of the income and expenditure of the company for that year. In preparing those financial statements, the directors are required to: • select suitable accounting policies and then apply them consistently; • make judgements and estimates that are reasonable and prudent; and • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors confirm that they have complied with the above requirements in preparing the financial statements. The directors are responsible for keeping proper books of account which disclose with reasonable accuracy at any time the financial position of the company and to enable them to ensure that the financial statements are prepared in accordance with the accounting standards generally accepted in Ireland and comply with the Irish Companies Acts, 1963 to 1983 and 1990 to 2012. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Going Concern Based on committed subscription fee income from stakeholder organisations over the next year and other forecast income, the directors are satisfied that Animal Health Ireland Initiative has adequate resources to continue for at least 12 months from the date of approval of these financial statements and it is appropriate to adopt the going concern basis in the preparation of the financial statements. Books of Account The measures taken by the directors to secure compliance with the company’s obligations to keep proper books of account are the use of systems appropriate to the business and the employment of competent and reliable persons. Legal Status Animal Health Ireland Initiative is a company incorporated under the Companies Acts, 1963 to 1983 and 1990 to 2012 limited by guarantee and not having a share capital. Animal Health Ireland Initiative is a not for profit organisation set up to enhance value for livestock farmers and the agrifood industry through superior animal health. All income to the company is applied towards the running of the organisation.

An i ma l H e a lt h I r e l and

28

Directors’ Report (continued) Directors The names of the persons who were directors at anytime during the period ended 31st December 2012 are set out below. Unless indicated otherwise, they served as directors for the entire period. • Mike Magan (Chairman)

• Gerard Brickley • John O’Sullivan

• Laurence J. Collins • Michael Doherty • Robin Herbert Talbot

Principal Activities and Date of Incorporation Animal Health Ireland Initiative was incorporated on 11th May 2009 as a Company Limited by Guarantee and not having a share capital. Its principal activities are to promote awareness and education and to coordinate effective control programmes for non-regulated diseases of livestock.

Results True results for the financial year are set out on pages 32 to 40.

Subsequent Events There have been no significant events affecting the company since the year end.

Transaction involving Directors There were no contracts of any significance in relation to the affairs of the company in which the directors had any interest, as defined in the Companies Acts, 1990, at any time during the year ending on 31st December 2012. Auditors The auditors, Spain, Fewer Quinlan & Co., have indicated their willingness to continue in office in accordance with the provisions of Section 160(2) of the Companies Act, 1963.

on behalf of the Board

Mike Magan 27th September 2013

Gerard Brickley

Annua l R e p o r t 2012 29

Independent Auditors’ Report to the Members of Animal Health Ireland Initiative (A Company Limited by guarantee and not having a share capital)

We have audited the financial statements on pages 32 to 34 and the related Notes on pages 36 to 40. These financial statements have been prepared under the accounting policies set out on page 35. Respective responsibilities of directors and auditors Thedirectors’ responsibilities for preparing thefinancial statements inaccordancewith the accounting standards issued by the Accounting Standards Board and published by The Institute of Chartered Accountants in Ireland (Generally Accepted Accounting Practice in Ireland) are set out in the Statement of Directors’ Responsibilities on pages 28 to 29. Our responsibility is to audit the financial statements in accordance with relevant legal and statutory requirements and International Standards on Auditing (UK and Ireland). This report, including the opinion, has been prepared for and only for the company’s members as a body in accordance with Section 193 of the Companies Act, 1990 and for no other purpose. We do not, in giving this opinion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. We report to you our opinion as to whether the financial statements give a true and fair view, in accordance with Generally Accepted Accounting Practice in Ireland applicable to, and are properly prepared in accordance with Irish statute comprising the Companies Acts, 1963 to 1983 and 1990 to 2012. We state whether we have obtained all the information and explanations we consider necessary for the purposes of our audit and whether the financial statements are in agreement with the books of account. We also report to you our opinion as to: • Whether the company has kept proper books of account; and • Whether the directors’ report is consistent with the financial statements. We also report to you if, in our opinion, any information specified by law regarding directors’ remuneration and directors’ transactions is not disclosed and, where practicable, include such information in our report. We read the directors’ report and consider the implications for our report if we become aware of any apparent We conducted our opinion in accordance with International Standards on Auditing (UK and Ireland) issued by the Auditing Practices Board. An audit includes examination, on a test basis, of evidence relevant to the amounts and disclosures in the financial statements. It also includes an assessment of the significant estimates and judgements made by the directors in the preparation of the financial statements, and of whether the accounting policies are appropriate to the company’s circumstances, consistently applied and adequately disclosed. We planned and performed our audit so as to obtain all the information and explanations which we consider necessary in order to provide us with sufficient evidence to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or other irregularity of error. In forming our opinion we also evaluated the overall adequacy of the presentation of information in the financial statements. misstatements within it. Basis of Audit Opinion

An i ma l H e a lt h I r e l and

30

Independent Auditors’ Report to the Members of Animal Health Ireland Initiative (continued)

Opinion In our opinion the financial statements:

• give a true and fair view of the state of the company’s affairs at 31 December 2012 and of its income and expenditure for the year then ended, in accordance with Generally Accepted Practice in Ireland. • have been properly prepared in accordance with the Companies Acts, 1963 to 1983, and 1990 to 2012. • We have obtained all the information and explanations we consider necessary for the purposes of our audit. In our opinion proper books of account have been kept by Animal Health Ireland. The financial statements are in accordance with the books of account. In our opinion the information given in the directors’ report on pages 28 to 29 is consistent with the financial statements. M.G Spain for and on behalf of Spain, Fewer Quinlan & Co. Chartered Accountants and Registered Auditors Thurles 27th September 2013.

Annua l R e p o r t 2012 31

Income and Expenditure Account for the year ended 31st December 2012

€ 929,441 70,456 999,897 (1,095,415) (95,518) - (95,518) 69,128 (26,390) 12 Months to 31 Dec 2012

11 Months to 31 Dec 2011

Note

€ 908,650 7,600 916,250 (892,537) 23,713 -

Income from Stakeholders’ Subscriptions Other Income Total Income Operating Expenses Surplus/(Deficit) on Ordinary Activities before Taxation Tax on Surplus on Ordinary Activities Surplus on Ordinary Activities after Taxation Retained Surplus/(Deficit) at beginning of financial year Retained Surplus/(Deficit) at end of financial year

2,3,4 5

23,713 45,415 69,128

There are no recognised gains or losses other than the surplus attributable to members of the Company for the above two financial years.

on behalf of the Board

Mike Magan 27th September 2013

Gerard Brickley

An i ma l H e a lt h I r e l and

32

Balance Sheet as at 31st December 2012

31 Dec 2012 31 Dec 2011

Note

€ 17,704

€ 16,688

Fixed Assets Current Assets Stocks Debtors Cash at Bank

6

20,150 30,300 31,841 82,291 (126,385) (44,094) (26,390) - (26,390)

- 99,880 84,159 184,039 (131,599)

7

Creditors: amounts falling due within one year Net Current Assets Total Assets less Current Liabilities Creditors: amounts falling due greater than one year Total Net Assets Financed By: Revenue Reserves Account Member’s Funds

8

52,440 69,128 - 69,128

(26,390) (26,390)

69,128 69,128

13

on behalf of the Board

Mike Magan 27th September 2013

Gerard Brickley

Annua l R e p o r t 2012 33

Cashflow Statement for the period ended 31 December 2012

12 Months to 31 Dec 2012

11 Months to 31 Dec 2011

Note

Reconciliation of Operating Surplus to Net Cash Inflow from Operating Activities (Deficit)/Surplus on Ordinary Activities after Taxation

(95,518)

23,713

3,108

Depreciation

2,377

(20,150)

(Increase in Stocks)

-

69,580

Decrease / (Increase) in operating debtors and prepayments

22,230

(5,214)

Increase / (Decrease) in operating creditors and accruals

6,175

(48,194)

Net Cash (Outflow)/Inflow from Operating Activities Increase in Cash in Period from Operating Activities Capital Expenditure and Financial Investment Payments to acquire tangible Fixed Assets (Decrease) / Increase in Cash (Decrease)/Increase in Cash in the year / period

53,495

(48,194)

54,495

(4,124)

(7,355)

(52,318) (52,318)

47,140 47,140

84,159

Opening Bank Balance at start of the year / period

37,109

31,841

84,159

Closing Bank Balance at start of the year / period

An i ma l H e a lt h I r e l and

34

Statement of Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company’s financial statements. Accounting Convention The financial statements are prepared under the historical cost convention in accordance with accounting standards generally accepted in Ireland and Irish statute comprising the Companies Act 1963 to 2012. Accounting Standards generally accepted in Ireland in preparing financial statements giving a true and fair view are those issued by the Accounting Standards Board. The financial statements are expressed in Euro (€). Income The Company’s primary source of income consists of stakeholders’ subscriptions. These funds are recognised in the financial statements on an accrual basis. Income received from stakeholders, including the Department of Agriculture, Food and the Marine (DAFM) is credited to the income and expenditure account so as to match it with the expenditure to which it relates. (Please also refer to policy on Government Grants). The company also earns some service income from the provision of educational training courses to veterinary practitioners and others regarding disease control and eradication. In addition the Company levies Stakeholder Organisations, and other interested bodies and individuals a charge equivalent to the cost of delivering literature, guides and other educational material, so that the Company is in a no gain, no loss position. Government Grants Government grants are provided through the Department of Agriculture, Food and the Marine (DAFM) as annual stakeholder subscriptions to Animal Health Ireland Initiative (AHI). They are recognised in the profit and loss account to match them with the expenditure towards which they are intended to contribute. (Note- no government grants in respect of capital expenditure have been received to date by AHI.) Expenditure All expenditure to date has been written off and no value is attributed to unexpired costs or research projects completed to date. Fixed Assets & Depreciation Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost each asset systematically over its expected useful life, as follows:

Office Equipment - 12.5% Straight Line Fixtures and Fittings - 12.5% Straight Line

Annua l R e p o r t 2012 35

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Page 38 Page 39 Page 40 Page 41

Made with FlippingBook - professional solution for displaying marketing and sales documents online